期刊文献+

系统性红斑狼疮患者T淋巴细胞CD70基因表达及其启动子区域甲基化状态的研究 被引量:6

Expressions of CD70 mRNA and protein and methylation status of CD70 gene promoter in T cells frompatients with systemic lupus erythematosus
原文传递
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者T淋巴细胞CD70mRNA和蛋白的表达及CD70基因启动子DNA甲基化的状态。方法分离15例活动期SLE患者、15例非活动期SLE患者和15例健康对照外周血CD4+与CD8+细胞,用实时定量逆转录PCR(RT-PCR)方法检测CD4+和CD8+细胞CD70mRNA转录水平,流式细胞仪检测CD4+CD70+细胞和CD8+CD70+细胞百分率,亚硫酸氢钠基因测序法检测CD4+细胞和CD8+细胞CD70基因启动子区域甲基化水平。组间比较采用单因素方差分析,组间两两比较采用SNK-q检验。结果①活动期、非活动期SLE患者CD4’细胞CD70mRNA转录水平分别为0.82±0.12和0.73±0.11,明显高于健康对照组(O.45±0.09),F=53.017,P〈0.01,活动期SLE患者CD4细胞的CD70mRNA转录水平显著高于非活动期SLE患者(P〈0.05)。活动期、非活动期SLE患者外周血CD4+CD70+细胞百分率分别为80.30%±11.04%和66.80%±3.98%,明显高于健康对照组(12.48%±3.45%),F=311.517,P〈0.01,活动期SLE患者CD4+CD70+细胞百分率显著高于非活动期SLE患者(P值〈0.05)。SLE患者外周血CD70+CD4+细胞百分率与SLE疾病活动度呈显著正相关(r=0.792,P=0.000)。活动期、非活动期SLE患者组的CD4+细胞CD70基因启动子序列-60~-300bp区域平均甲基化水平分别为0.32±0.05和0.36±0.05,明显低于健康对照组(0.62±0.05),F=152.64,P〈0.01,活动期平均甲基化水平明显低于非活动期SLE患者组(P〈0.05)。结论CD4+细胞CD70基因启动子区域处于低甲基化状态,这种低甲基化状态可能是CD70过度表达的直接原因。 Objective To detect the expressions of CD70 mRNA and protein and to determine the methylation status of CD70 gene promoter in T cells from patients with systemic lupus erythematosus (SLE). Methods Peripheral blood CD4+ and CD8+ T cells were isolated from 15 patients with active SLE, 15 patients with inactive SLE and 15 healthy control subjects. Real-time quantitative reverse transcription-PCR was carried out to quantify the mRNA expression of CD70, flow cytometry to determine the frequency of CD4+CD70+and CD8+ CD7+ T cells, and bisulfite sequencing to evaluate the methylation status of CD70 gene promoter in CD4+ and CD8+ T cells. Differences in these parameters among these groups were analyzed by one-factor analysis of variance and SNK-q test. Results Compared with the healthy controls, the patients with active SLE and inactive SLE showed a significant increase in CD70 mRNA expression in CD4+ T cells (0.82 ± 0.12 and 0.73 ± 0.11 vs. 0.45 ±0.09, F = 53.017, P 〈 0.01 ) and in the frequency of CD70+CD4+ T cells (80.30% :1:11.04% and 66.80%± 3.98% vs. 12.48% ±3.45%, F = 311.517, P 〈 0.01). Also, the expression of CD70 mRNA in CD4+T cells and the frequency of CD70+CD4+ T cells were significantly higher in patients with active SLE than in patients with inactive SLE (both P 〈 0.05). There was a positive correlation between the frequency of peripheral CD70+CD4+ T ceils and disease activity in SLE in these patients (r = 0.792, P 〈 0.01). The average methylation index of the region between -600 bp and -300 bp of CD70 gene promoter in CD4+ T cells was 0.32 ± 0.05 and 0.36 ± 0.05 respectively in the patients with active and inactive SLE, significantly lower than that in the healthy controls (0.62 :t: 0.05, F = 152.64, P 〈 0.01 ), and the patients with active SLE showed a significantly lower methylation index than those with inactive SLE (P 〈 0.05). Conclusions The CD70 gene promoter in CD4+T cells is significantly hypomethylated in natients with SLE. which may directly lead to the overexoression of CD70.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2013年第2期80-83,共4页 Chinese Journal of Dermatology
基金 海南省自然科学基金(309079)
关键词 红斑狼疮 系统性 T淋巴细胞 抗原CD70 DNA甲基化 Lupus erythematosus, systemic T-lymphocytes Antigens, CDT0 DNA methylation
  • 相关文献

参考文献11

  • 1Ansel KM,Lee DU,Rao A. An epigenetic view of helper T cell differentiation[J].Nature Immunology,2003,(07):616-623.doi:10.1038/ni0703-616.
  • 2Sekigawa I,Kawasaki M,Ogasawara H. DNA methylation:its contribution to systemic lupus erythematosus[J].Clinical and Experimental Medicine,2006,(03):99-106.
  • 3Lu Q,Kaplan M,Ray D. Demethylation of ITGAL (CD11 a)regulatory sequences in systemic lupus erythematosus[J].Arthritis and Rheumatism,2002,(05):1282-1291.
  • 4Kaplan MJ,Lu Q,Wu A. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells[J].Journal of Immunology,2004,(06):3652-3661.
  • 5Lu Q,Wu A,Tesmer L. Demethylation of CD40LG on the inactive X in T Cells from Women with Lupus[J].Immunology,2007,(09):6352-6358.
  • 6李遇梅,李安生,姚煦,徐冠东,弓娟琴,陈志强.系统性红斑狼疮患者血浆DNA p16基因启动子的甲基化状态[J].中华皮肤科杂志,2005,38(7):419-422. 被引量:8
  • 7Tan EM,Cohen AS,Fries JF. The 1982 revised criteria for the classification of systemic lupus erythematosus[J].Arthritis and Rheumatism,1982,(11):1271-1277.
  • 8Bombardier C,Gladman DD,Urowitz MB. Derivation of the SLEDAI.A disease activity index for lupus patients.The Committee on Prognosis Studies in SLE[J].Arthritis and Rheumatism,1992,(06):630-640.
  • 9Font J,Pallares L,Martorell J. Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus[J].Clinical Immunology and Immunopathology,1996,(03):239-243.
  • 10肖嵘,李勇坚,陆前进,李亚萍,丁艳,杨心洁,周英,张静,李干群,梁云生,文海泉.SLE患者T淋巴细胞穿孔素基因启动子区域甲某化状态的探索[J].中华皮肤科杂志,2007,40(2):89-91. 被引量:4

二级参考文献15

  • 1李勇坚,肖嵘,李亚萍,张桂英,丁艳,杨心洁,张静,苏玉文,陆前进,文海泉.SLE患者T淋巴细胞穿孔素mRNA及其蛋白的表达[J].中华皮肤科杂志,2007,40(1):57-58. 被引量:1
  • 2Herkel J, Mimran A, Erez N, et al. Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to antiDNA antibodies. J Autoimmun, 2001, 17: 63-69.
  • 3Kuo P, Bynoe MS, Wang C, et al. Bcl-2 leads to expression of antiDNA B cells but no nephritis: a model for a clinical subset. Eur J Immunol, 1999, 29: 3168-3178.
  • 4Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Bheum,1982, 25: 1271-1277.
  • 5Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
  • 6Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996, 93: 9821-9826.
  • 7Sherr CJ. Cancer cell cycles. Science, 1996, 274: 1672-1677.
  • 8Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 1995, 55: 4525-4530.
  • 9Seelig HP, Ehrfeld H, Renz M. Interferon-gamma-inducible protein p16. A new target of antinuclear antibodies in patients with systemic lupus erythematosus. Arthritis Rheum, 1994, 37: 1672-1683.
  • 10Richardson B, Powers D, Hooper F, et al. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum, 1994, 37: 1363-1372.

共引文献10

同被引文献81

  • 1张炜,陈官芝,王海滨,苏厚恒,孙迎娟,罗兵.EB病毒潜伏基因表达与系统性红斑狼疮的关系[J].中国皮肤性病学杂志,2005,19(7):404-406. 被引量:3
  • 2陈官芝,张炜,李惠,谭霞,罗兵.系统性红斑狼疮患者中Epstein-Barr病毒增殖期基因的表达[J].中华皮肤科杂志,2006,39(1):13-15. 被引量:2
  • 3Draborg AH, Duus K, Houen G. Epstein-Barr virus and systemic lupus erythematosus[J]. Clin Dev Immunol, 2012, 2012: 370516.
  • 4Larsen M, Sauce D, Deback C, et al. Exhausted cytotoxic control of Epstein-Barr virus in human lupus [J]. PLoS Pathog, 2011, 7 (10): e1002328.
  • 5Tan EM, Cohen AS, Fries JF, et aI. The 1982 revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1982, 25( 11): 1271-1277.
  • 6Gross AJ, Hochberg D, Rand WM, et al. EBV and systemic lupus erythematosus: a new perspective[J]. J Immunol, 2005,174(11): 6599-6607.
  • 7Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseaseslJJ. Autoimmunity, 2008, 41(4): 298-328.
  • 8Peters AI.., Stunz LI.., Meyerholz OK, et al. Latent membrane protein I, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Slel mice [I]. J Immunol, 2010, 185 (7): 4053-4062.
  • 9Yurasov S, Wardemann H, Hammersen J, et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus [J]. J Exp Med, 2005, 201(5): 703-711.
  • 10Pratesi F, Tommasi C, Anzilotti C, et al. Deiminated Epstein-Barr virus nuclear antigen I is a target of anti-citrullinated protein antibodies in rheumatoid arthritis [J]. Arthritis Rheum, 2006, 54 (3): 733-741.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部